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Utrophin, the autosomal dystrophin-related protein (DR.P), is expressed in HeLa cells, smooth muscle-like BC~HI cells from mouse brain, COS 
monkey kidney ceils, the P3BBDt monocyte-macrophag¢ cell line and untransformed human skin fibroblasts, as well a5 in rat C6 gliomit and 
Schwannoma cells. It was undetectable, however, in th~ Sp~O mouse m:/eloma cell line and in hybridoma lines derived from it. Dy.~trophin wa~ 
not detected in an~, of these cell lines. Although all utrophin-coata.ininB cells were capable of forming monola),ers inculture, no major effects of 
either attachment to substratum or length of time in culture (2-17 days) on utrophin levels were observed. After subcellular f actionation fBCsH ! 
or glioma cells, nearly all of the atrophin was found in the Triton.soluble fraction, suggesting an association with cell membranes. 
Dystrophin; Dystrophin-related protein; Mttsealar dystrophy; DMDL gene; Membmne-asso,~iated protein 
1. INTRODUCTION 
Utrophin (dystrophin-related protein, DMDL pro- 
tein; DRP)  [1--4] is an autosomal  homologue o f  dystro- 
phin, the protein affected by mutat ion in Duchenn¢ and 
Backer muscular dystrophies [5], Unl ike dystrophin 
which is mainly restricted to muscle, utrophin has been 
found in all tissues examined, particularly in nerve fi. 
bres, smooth muscle (especially that o f  the vascular sys- 
tem) and b lood vessels. In adult skeletal muscle, it is 
restricted to neuromuscular  junct ions [4,6], but  is more 
generally distributed in the sarcolemma in foetal muscle 
[2], in regenerating muscle fibres [7] and in the majority 
of fibres f rom patients with muscular dystrophies [4,8] 
or inf lammatory myopathies [7]. The protein is also 
abtmdant in t ransformed brain cell lines, C6 glioma and 
SWA Schwannoma [4], 
A l though utrophin is found in tissues such as lung, 
liver, kidney and spleen [3], its localization has not been 
reported and the possibility remains that it could be 
restricted to the nerve and smooth muscle components  
of  these tissues. We now show, however, that utrophin 
is present in many cell types in culture, including six 
tttmour cell lines of  different origins and untransformed 
human skin fibroblasts, The results raise the question 
of  whether dystrophin can be reasonably regarded as a 
specialized muscle/nerve i.~oform of  utrophin.  
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2. MATERIALS  AND METHODS 
2 1. Cell lim,3' 
Human skin fibroblasts after several passage~ in culture were kindly 
provid~ by Dr. John Butterworth (Royal Hospital for Sick Childrm, 
Edinburgh). The Sp~O mou~ myeloma cell line is our standard cell 
line for hybridoma production and the MANDYSI hybridoma pro- 
duciag antibody against dystrophin has been described previously [9]. 
The SWA rat Schwannoma ~11 line [10] was provided by Dr. George 
Dickson (Guy'~ Hospital M~Micai S~hool, Londoll). All other gall ines 
are available from the Eu:opeaa Coll~tlon of Animal Cell Cultures 
(Porton Down, Salisbury, UK) a~=d the American T2ipe Culture Col- 
lection (R.ockville, MD, USA). COS-I are $¥40-transformed African 
Green monkey fibroblast-likc idney cells (ATCC CRL 1650), P388D~ 
are monoeyte-macrophage cells from a mou~e lymphoid neoplasm 
(ATCC TIB 63), BC~HI are smooth muscle-like cells obtained from 
a mouse brain turnout (ATCC CRL 1443), HeLa S3 are epithelial-like 
cells from a human cervical eaminoma (ATCC CCL 2.2) and C6 arc 
81ial cells from a rat glial tumour (ATCC CCL 107). AI~ ~lls were 
~rown in DMEM + 10% selected horse serum, except hat 0.1 mM 
ZnCI: wa~ added to SWA cultures [10] and DMEM was replaced by 
Joklik's MEM for HeLa suspension eultur~. 
2.2. Westertt blots 
Cultures ~lls were harvested in PBS and cell pellets were boiled in 
62.5 mM Tris-HCl, pH 6.8, conlaining 2% SDS, 5% 2-mercaptoetha. 
nol and 5% sueror, e (4 ml/ml of ceU pellet) and centrifuged at 13,000 
rpm in an Eppendorf centrifuge for I0 min. Extracts (10/.tl) were 
loaded onto 4-12.~% gradient gels with a 4% staekin Bl~ei, tot~ether 
with 5/al ofprestained molecular weight markers (Si~-na; 180, 116, 84, 
58, 48.5, 36.5 and 26.6 kDa; I mg/ml ofeachL After ¢lectrophoresis, 
proteins were transferred electrophoretieaily [BioRad Traasblot) to 
nitrocellulose heets (Schleieher and Schuel, BA~5) at 1~0 mA over- 
night in 25 ram Tri% 192 mM glycine, 0.003% SDS. 
Blots were blocked in 3% skimmed milk powder in incubation 
buffer (0.05% Triton X- 109 in phosphate-buffered saline (PBS: 25 mM 
.~odium phosphate, pH 7.2, 0.9% Noel). After two 5.rain washes in 
P~S, blots were incubated with monoelonal ntibody culture superna- 
lant (1/i00 dilutlon in incubation ball'at/! % horse serum/1% foetal calf 
serum/0.3% bovine serum albumin) for I h at 20°C. After three 5.rain 
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washes with PBS, blots were incubated with biotinylated anti-(mouse 
lg) and a p~roxidas¢-avidin etection reagent (V¢~tastain ABC kit), 
accordin 8 to the manufacturer's instructions (Vector Laboratories). 
After four 5.rain washes with PBS, substrate was added (0.4 mg/ml 
diaminobenzidine (Sigma) in 25 mM phosphate-citrate buffer, pH 5.0, 
with 0.012% H,O:. 
2.3. Cellfractlonation 
Monolayer cultures of BC3HI cells (five 90 mm Petri dishes) wore 
rinsed with PBS and thorouglaly drained before harvesting seqaen. 
tially with the same 0.4 ml of 10 mM Tris-HCI, pH 6.7, using a rabbgr 
policeman. The cell suspension was placed in a 1.5 ml microcentrifit~e 
tube and cooled to 4°C before sonicating with a microprobe (2 mm 
tip) at 22~um amplitude. Centrifugation was performed ina Bcckmann 
50Ti rotor at 40,000 rpm and 40C. TILe pellet was resuspended in 0.4 
ml of 1% Triton X-100 ia 10 mM Tris-HCl, pH 6.7, and centrifuged 
a~ain. Fractions were adjusted to 50 mM Tris-HCl, pH 6.8, 2~ SDS, 
5% 2-mereaptoethanol and 5% sucrose in the same final volume (ca. 
0.3 ml recovered) b=tore boiling Ibr 2 rain. 
3. RESULTS 
In Fig. la, utrophin from rat glioma cells is shown 
co-migrating with mouse muscle dyslrophin at 400 kDa 
as previously described [4], using a monoclonal anti- 
body which reacts with both proteins (MANCHO11). 
The HeLa cell extract also shows a band of utrophin at 
400 kDa (H: Fig. In) which is detected by mAbs against 
several different epitopes on utrophin but is not de- 
tected by dystrophin-specific antibodies ([4] and data 
not shown). Fig. lb shows that utrophin is present in 
HeLa cells grown both in suspension culture and on 
tissue culture plastic. In the latter case, utrophin levels 
were similar in firmly-attached cells (Ha4) and floating 
cells (Hs4) from the same 4-day culture and in confluent 
17-day attached cultures (Fig. lb). Similarly, no clear 
change in utrophin levels could be seen as C6 glioma 
cells grew to confluency between 2 and 4 days in culture, 
though this method would not reliably detect small 
changes (Fig. It). 
Fig. 2 shows that utrophia-specific mAbs detect he 
400 kDa band in COS monkey kidney cells, P388D~ 
macrophage-like c lls and human skin fibroblasts as 
well as in glioma and Schwannoma cells, but not in 
either Sp2/O myeloma cells or a hybridoma cell line 
derived from a fusion between Sp2/O and mouse spleen 
cells. This last extract contains large amounts of mouse 
Ig (mAb MANDYSI) which explains the major bands 
of 50 kDa pro':ein (H-chain) and aggregated material on 
the Western blot. The band at about 52 kDa present in 
most extracts is a non-specific cross-reaction of the sec- 
ond antibody detection system. The large number of 
bands between 60 kDa and 180 kDa is striking in the 
glioma and Schwannoma extracts (Fig. 2 and lc). These 
appear to be utrophin-related bands rather than cross- 
reactive bands, since they are recognized by mAbs 
against several different utrophin epitopes (data not 
shown). Degradation cannot be ruled out at this stage, 
though there is no apparent reason why degradation 
should be greater in these two cell lines than in others. 
Fig. 3 shows that utrophin is also found in the BC3H l 
smooth muscle-like cell line and that it is not present in 
the soluble cytoplasmic fraction of these cells, but is 
almost completely extracted from the insoluble pellet by 
the non-ionic detergent, Triton X-100. Dystrophin is 
known to be membrane°associated at~d is extracted 
from muscle in the same way [1 I]. This suggests that 
utrophin is also associated in some way with mem- 
branes, especially since two integral membrane proteins 
we have examined, N-CAM and the 43 kDa dystrogly- 
can component [12], are also found exclusively in the 
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Fig. 1. Utrophin in C6 glioma cells (G) and HcLa cells (H) under different growth c,,aditioas. (a) Uttophin in glioma and HeLa cells comigrates 
with dystrophin from mouse muscle (Mu). The mAb used, MANCHOII, reacts with both proteius. (b) Utrophir, levels arc similar in HcLa ¢¢1h 
maintained in suspension culture in Joklik's MEM (Hsl, HeL.'t cells attached to tissue culture flasks alter 4 days (Ha4) or 17 days (Hal7) growth 
in Dalbeceo's MEM and cells from the same 4 day culture which were unattached to the substratum ('floaters', Hs4). The Mr markers visible are 
116 kDa and 180 kDa and the mAb was MANCHOI 1. (c) No detectable change in utrophin levels in C6 glioma cells cultured tbr 2 days (G2), 
3 days (G3) or 4 days (G4). The mAb was utrophia-spccif'tc, MAhTCHO3, and HoLe cell cnract is shown as a control (H). 
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fibroblasts, but not in lnyeloma or hybridoma cells. The cell lines 
shown are CO$-1 monke:¢ kidney (CO), SWA rat Schwannoma 
(SWA), C6 glioma (G), Sp~O mouse myeloma (My), P388D~ mouse 
monocyte-macropha~e (P3), huraan skin fibroblasts (Fi) and the 
MANDYSI mouse h),bridoma (Hy). The heavy staining in (Hy) re- 
ffleets the.orodttetion l"~ar~ amottftta nt'_mo.tt,~_l~ ,~ki~ .r.czt~L~ . tttt 
the 5econt] antibody detection syntem. Th~ utrophin-speeific mAbs 
u~ed were MANCHO7 (Co, P3, Hy) and MANCHO3 (Sw, G, My). 
Triton X'-tu% fraction fmanuscript su6mitte6). A simi- 
Iar result was obtained using C6 glioma cells (not 
shown). 
4. DISCUSSION 
Utrophin eDNA was originally isolated from a fetal 
muscle library [1] and subsequent s udies on utrophin 
itself have been consistent with a primary role for this 
protein in muscle and nerve tissues, like dystrophin it- 
self. Thus~ it was shown that utrophin was present at 
adult skeletal neuromuscular junctions [406,13], in vas- 
cular and myometrial smooth muscles [4] and in nerve 
fibres [2]. We have also shown that it is present in pro- 
liferating brain cell lines (glioma and Schwannoma) [4] 
and have suggested that its high levels in lung might be 
due to the high l;roportion of vascular and other 
smooth muscles in this ttssue [4]. 
We have now shown, however, that utrophin is ex- 
pressed in most transformed continuous cell lines with 
a variety of developmental origins, though none of these 
express detectable amounts of dystrophin. It is also 
present in signifie=mt amounts in untransformed human 
skin fibroblast cultures, potentially useful for studies of 
normal and pathological variation in utrophin in 
human populat:.ons, ince they are one of the easiest 
human cell cultures to establish. 
Since utrophin is present at higher levels in foetal and 
. . . . . . . . .  ~n~ rv~, ,onba  i t=  pro=anPe in cultured cells mieht 
seem con~iste~t with ~ relationship with cell prolifera- 
tion. Utrophin was ~bsent, however, from the mouse 
myeloma cell line tested and from hybridomas resulting 
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Fig. 3. Utrophin in BC~Hi .~mooth mmcle-lik¢ ce l l s  is insoluble in 
proced~Jre is deserilx~l in Materia[~ and Methods. The fractions are 
a low.salt "cytoplasmic' fraction ($), the Triton-~olubi¢ fraetlon of the 
low-salt pellet (T) and the Triton-insoluble pellet (P). The mAb u~'d 
~vas Utl'ophin-slx'eilie MANCHO3. 
from its fusion with mouse spleen iymphocytes. This 
shows that utrophin is not essential for cell growth and 
division. The myeloma ¢¢11 line is the only one which 
grows in suspension and does not attach readily to tis- 
sue culture plastic. Akhough HeLa cells grow in suspen- 
sion, they can also attach to plastic, but no diffelence 
in utrophin content was observed when attached and 
'floating' cells were compared in a culture containing 
both (Fig. l b). This does not rule out the possibility that 
utrophin is required for cell attachment and spreading, 
though utrophin levels do not show any marked change 
in response to changes in the~ factors. The results 
clearly show the need to look beyond any specialized 
utrophin function in muscle and nerve to a more general 
function, certainly in transformed cells and perhaps in 
most normal cells in culture. 
The evidence that utrophin is associated with mem- 
branes is significant sin~ this has so far only been 
clearly demonstrated in muscle. This may be partly due 
to the fact that the plasmalemma is easier to differenti- 
ate immunohistochemieally from cytoplasm in large 
muscle fibres than in tissues made up of much smaller 
cells. Extraction with Triton X-100 does not, of coarse, 
distinguish between the plasma membrane fraction and 
any internal microsomal membranes and there is evi- 
dence that even dystrophin itself can associate with in- 
ternzl membranes such as transverse tubules under 
some circumstances [14,15]. The possibility that Triton 
releases utrophin by a m~hanism other than its soiubii- 
ization of membranes, though unlikely, cannot be for- 
maily ruled out. Dystrophin, however° is also extracted 
21 
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from muscle by Triton X-100 [l I] and, by analogy, any 
utrophin interaction with membrane lipids is likely to 
be indirect. Dystrophin interacls with membranes vid 
the dystrophin-associated glyccrp~~~ciit oomplex (DAG) 
which is also present in non-muscle tissues [12], but it 
has not yet been established whether utrophin can inter- 
act with trans-m+abranr! UAG (or ;1 +nilar protein) in 
the same way as dystrophin. It ip of i~:dt~t, IIv~YL.ucI, 
that DAG interacts extracellutarly with lbe basement 
membrane protein, laminin. [12] and that some cultured 
cell monolayers can also expi;ess laminin. a fauture 
shared with utroyhin-containing tissue components, 
such as vascular smootl! muscle and nerve [ 161. 
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